arrow
Back
J

Joan Carles

Vall d'Hebron Barcelona Hospital Campus

55H-index
717Paper Count
2.0WCitation Count
Published Papers 145
Publication Date
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
err2026-10-14
err0
errOAAI
errFrancesca Zacchi; Elena Castro; Kathleen Imbach; Alejo Rodriguez-Vida; Sara Simonetti; Begoña Mellado; Gisela Mir Arnau; Daniel Aguilar; Daniel Castellano; Miguel Angel Climent; Manuel J. Ramos; Angel Borque-Fernando; Jose Antonio Guerrero; Paula Gonzalez-Alonso; Jhudit Perez-Escuredo; Vanessa Izquierdo; Maria Isabel Saez; Heura Domenech; Sara Arce-Gallego; Bernardo Herrera-Imbroda; Jacques Planas; David Lorente; Albert Font; Anna Oliveira; Pablo Cresta Morgado; Victor Esquefa; Julian Brandariz; Nicolas Anselmino; Keyi Zhu; Patricia Troncoso; Monica Aguilera; Ana Vivancos; Paolo Nuciforo; Irene Casanova-Salas; Eduard Porta; Joan Carles; Amado J. Zurita; Joaquin Mateo
errShare
errSave
Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]
err2025-11-13
err0
PREAI
errArun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
Age-related Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of the Phase 3 ARASENS Trial
err2025-11-04
err0
errOAAI
errJoan Carles; Bertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Álvaro Montesa Pino; Maria José Méndez-Vidal; Alejo Rodriguez-Vida; Daniel Castellano; Pablo Borrega; Patrick Adorjan; Cristina Moretones; Manjari Dissanayake; Matthew R. Smith
errShare
errSave
Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive review
err2025-10-30
err0
PREAI
errClara Salva de Torres; Ernesto Trallero-Araguas; David Marmolejo; José Maria Ucha Hermida; Nely Díaz Mejía; Pau Mascaró Baselga; Abraham André Arturo Geng-Cahuayme; Laia Catalan; Macarena González; Rafael Morales-Barrera; Joan Carles; Enrique Gallardo; Cristina Suárez
errShare
errSave
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; André P Fay; Nobuaki Matsubara; Cezary Szczylik; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Fred Saad; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Xun Lin; Cynthia G Healy; Matko Kalac; Dana Kennedy; Karim Fizazi
errShare
errSave
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
err2025-07-16
err0
PREAI
errKarim Fizazi; Arun A Azad; Nobuaki Matsubara; Joan Carles; André P Fay; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Dingwei Ye; Xun Lin; Matko Kalac; A Douglas Laird; Dana Kennedy; Neeraj Agarwal
errShare
errSave
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial
err2025-06-13
err0
PREAI
errNeeraj Agarwal; Arun A Azad; Joan Carles; Nobuaki Matsubara; Stéphane Oudard; Fred Saad; Axel S Merseburger; Andrey Soares; Bradley A McGregor; Bogdan Zurawski; Marinos Tsiatas; Scott North; Igor Bondarenko; Margarita Alfie; Evangelos Bournakis; Lorenzo Antonuzzo; Lena Evilevitch; Andrew Simmons; Fong Wang; Roberta Ferraldeschi; Prachi Nandoskar; Sumanta K Pal
errShare
errSave
Corrigendum to “Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients” [Eur. Urol. Oncol. 7 (2024) 954–964]
err2025-05-01
err0
PREAI
errNatalia Jiménez; Marta Garcia de Herreros; Òscar Reig; Mercedes Marín-Aguilera; Caterina Aversa; Laura Ferrer-Mileo; Samuel García-Esteve; Leonardo Rodríguez-Carunchio; Isabel Trias; Albert Font; Alejo Rodriguez-Vida; Miguel Ángel Climent; Sara Cros; Isabel Chirivella; Montserrat Domènech; Mariona Figols; Joan Carles; Cristina Suárez; Daniel Herrero Rivera; Enrique González-Billalabeitia; Claudia Cívico; Núria Sala-González; Vicenç Ruiz de Porras; Maria J. Ribal; Aleix Prat; Begoña Mellado
errShare
errSave
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study
err2024-12-01
err0
errOAAI
errAzad, Arun A.; Fizazi, Karim; Matsubara, Nobuaki; Saad, Fred; De Giorgi, Ugo; Joung, Jae Young; Fong, Peter C. C.; Jones, Robert J.; Zschaebitz, Stefanie; Oldenburg, Jan; Shore, Neal D.; Dunshee, Curtis; Carles, Joan; Fay, Andre P.; Lin, Xun; Deannuntis, Liza; Di Santo, Nicola; Zielinski, Michael A.; Agarwal, Neeraj
errShare
errSave
errShare
errSave
Five latent factors underlie response to immunotherapy
err2024-09-12
err0
errOAAI
errUsset, Joseph; Huber, Axel Rosendahl; Andrianova, Maria A.; Batlle, Eduard; Carles, Joan; Cuppen, Edwin; Elez, Elena; Felip, Enriqueta; Gomez-Rey, Marina; Lo Giacco, Deborah; Martinez-Jimenez, Francisco; Munoz-Couselo, Eva; Siu, Lillian L.; Tabernero, Josep; Vivancos, Ana; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria
errShare
errSave
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial
err2024-09-01
err6
PREAI
errGarcia-Ruiz, Alonso; Macarro, Carlos; Zacchi, Francesca; Morales-Barrera, Rafael; Grussu, Francesco; Casanova-Salas, Irene; Sanguedolce, Francesco; Gonzalez, Macarena; Cresta-Morgado, Pablo; de Albert, Matias; Garcia-Bennett, Josep; Marmolejo, David; Planas, Jacques; Roche, Sarai; Mast, Richard; Zatse, Christina; Piulats, Josep M.; Herrera-Imbroda, Bernardo; Regis, Lucas; Agundez, Laura; Olmos, David; Calvo, Nahum; Escobar, Manuel; Carles, Joan; Mateo, Joaquin; Perez-Lopez, Raquel
errShare
errSave
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
err2024-08-01
err4
errOAAI
errJimenez, Natalia; de Herreros, Marta Garcia; Reig, Oscar; Marin-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; Garcia-Esteve, Samuel; Rodriguez-Carunchio, Leonardo; Trias, Isabel; Font, Albert; Rodriguez-Vida, Alejo; Climent, Miguel Angel; Cros, Sara; Chirivella, Isabel; Domenech, Montserrat; Figols, Mariona; Carles, Joan; Suarez, Cristina; Rivera, Daniel Herrero; Gonzalez-Billalabeitia, Enrique; Civico, Claudia; Sala-Gonzalez, Nuria; de Porras, Vicenc Ruiz; Ribal, Maria J.; Prat, Aleix; Mellado, Begona
errShare
errSave
Plain language summary of the results from the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer
err2024-07-12
err1
errOAAI
errAgarwal, Neeraj; Azad, Arun A.; Carles, Joan; Fay, Andre P.; Matsubara, Nobuaki; Heinrich, Daniel; Szczylik, Cezary; Giorgi, Ugo De; Joung, Jae Young; Fong, Peter C.; Voog, Eric; Jones, Robert J.; Shore, Neal D.; Dunshee, Curtis; Zschabitz, Stefanie; Oldenburg, Jan; Lin, Xun; Healy, Cynthia G.; Di Santo, Nicola; Zohren, Fabian; Fizazi, Karim
errShare
errSave
TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) plus enzalutamide (ENZA) vs placebo (PBO) plus ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
err2024-04-05
err3
PREAI
errPiulats, Josep M.; Azad, Arun A.; Laird, A. Douglas; Matsubara, Nobuaki; Fizazi, Karim; Shore, Neal D.; Karsh, Lawrence; Liu, Glenn; Fay, Andre P.; Carles, Joan; Jones, Robert J.; Voog, Eric; Zschabitz, Stefanie; De Giorgi, Ugo; Yip, Steven M.; Mu, Xinmeng Jasmine; Lin, Xun; Engelsberg, Arne; Agarwal, Neeraj
errShare
errSave
Identification of a novel agnostic predictive multiomic signature via Elastic Net/Machine Learning in TALAPRO-2 ( TP-2), a phase 3 study of talazoparib (TALA) plus enzalutamide (ENZA) vs placebo (PBO) plus ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
err2024-04-05
err0
PREAI
errLiu, Glenn; Mu, Xinmeng Jasmine; Fizazi, Karim; Laird, A. Douglas; Matsubara, Nobuaki; Yip, Steven M.; Pu, Jie; Carles, Joan; Fay, Andre P.; Jones, Robert J.; Zschaebitz, Stefanie; Piulats, Josep M.; Joung, Jae Young; Roh, Whijae; Chelliserry, Jijumon; Di Santo, Nicola; Saul, Michelle; Azad, Arun A.; Agarwal, Neeraj
errShare
errSave
Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient
err2024-03-08
err0
errOAAI
errZacchi, Francesca; Carles, Joan; Gonzalez, Macarena; Maldonado, Xavier; Perez-Lopez, Raquel; Semidey, Maria Eugenia; Mateo, Joaquin
errShare
errSave
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial (vol 30, pg 257, 2024)
err2024-01-31
err1
errOAAI
errFizazi, Karim; Azad, Arun A.; Matsubara, Nobuaki; Carles, Joan; Fay, Andre P.; De Giorgi, Ugo; Joung, Jae Young; Fong, Peter C. C.; Voog, Eric; Jones, Robert J.; Shore, Neal D.; Dunshee, Curtis; Zschabitz, Stefanie; Oldenburg, Jan; Ye, Dingwei; Lin, Xun; Healy, Cynthia G.; Di Santo, Nicola; Laird, A. Douglas; Zohren, Fabian; Agarwal, Neeraj
errShare
errSave
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial
err2023-12-04
err40
errOAAI
errFizazi, Karim; Azad, Arun A.; Matsubara, Nobuaki; Carles, Joan; Fay, Andre P.; De Giorgi, Ugo; Joung, Jae Young; Fong, Peter C. C.; Voog, Eric; Jones, Robert J.; Shore, Neal D.; Dunshee, Curtis; Zschaebitz, Stefanie; Oldenburg, Jan; Ye, Dingwei; Lin, Xun; Healy, Cynthia G.; Di Santo, Nicola; Laird, A. Douglas; Zohren, Fabian; Agarwal, Neeraj
errShare
errSave